Date Filed | Type | Description |
02/14/2022 |
5
| BAUER EUGENE A (Director) has filed a Form 5 on Applied UV, Inc. |
09/29/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
02/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/05/2020 |
4
| BAUER EUGENE A (Director) has filed a Form 4 on Aevi Genomic Medicine, Inc.
Txns:
| Disposed/sold 165,715 shares
@ $0 Disposed/sold 28,571 options to buy
@ $8.19, valued at
$234k
Disposed/sold 50,000 options to buy
@ $6.7, valued at
$335k
Disposed/sold 20,000 options to buy
@ $7.01, valued at
$140.2k
Disposed/sold 20,000 options to buy
@ $4.83, valued at
$96.6k
Disposed/sold 20,000 options to buy
@ $1.32, valued at
$26.4k
Disposed/sold 50,000 options to buy
@ $1.55, valued at
$77.5k
Disposed/sold 3,530 warrants
@ $2.84, valued at
$10k
|
|
08/19/2019 |
4
| BAUER EUGENE A (Chief Medical Officer) has filed a Form 4 on Dermira, Inc.
Txns:
| Paid exercise price by delivering 844 shares
@ $7.91, valued at
$6.7k
Paid exercise price by delivering 908 shares
@ $7.91, valued at
$7.2k
Paid exercise price by delivering 986 shares
@ $7.91, valued at
$7.8k
Exercised 2,438 restricted stock units
@ $0 Exercised 2,850 restricted stock units
@ $0 Exercised 2,625 restricted stock units
@ $0 |
|
04/09/2019 |
4
| BAUER EUGENE A (Chief Medical Officer) has filed a Form 4 on Dermira, Inc.
Txns:
| Sold 35,000 shares
@ $15, valued at
$525k
Exercised 35,000 options to buy
@ $1.218, valued at
$42.6k
|
|
02/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/11/2018 |
4/A
| BAUER EUGENE A (Chief Medical Officer) has filed a Form 4 on Dermira, Inc.
Txns:
| Paid exercise price by delivering 329 shares
@ $9.58, valued at
$3.2k
Paid exercise price by delivering 843 shares
@ $9.58, valued at
$8.1k
Paid exercise price by delivering 908 shares
@ $9.58, valued at
$8.7k
Exercised 950 restricted stock units
@ $0 Exercised 2,437 restricted stock units
@ $0 Exercised 2,625 restricted stock units
@ $0 |
|
08/17/2018 |
4
| BAUER EUGENE A (Chief Medical Officer) has filed a Form 4 on Dermira, Inc.
Txns:
| Paid exercise price by delivering 329 shares
@ $9.58, valued at
$3.2k
Paid exercise price by delivering 843 shares
@ $9.58, valued at
$8.1k
Paid exercise price by delivering 908 shares
@ $9.58, valued at
$8.7k
Granted 50,000 restricted stock units
@ $0 Exercised 950 restricted stock units
@ $0 Exercised 2,437 restricted stock units
@ $0 Exercised 2,625 restricted stock units
@ $0 |
|
07/18/2018 |
4/A
| BAUER EUGENE A (Director) has filed a Form 4 on Aevi Genomic Medicine, Inc.
Txns:
| Granted 50,000 options to buy
@ $1.55, valued at
$77.5k
|
|
06/18/2018 |
4
| BAUER EUGENE A (Director) has filed a Form 4 on Aevi Genomic Medicine, Inc.
Txns:
| Granted 50,000 options to buy
@ $1.55, valued at
$77.5k
|
|
04/04/2018 |
4
| BAUER EUGENE A (Director) has filed a Form 4 on Cerecor Inc.
Txns:
| Granted 2,262 options to buy
@ $4.29, valued at
$9.7k
|
|
03/06/2018 |
4
| BAUER EUGENE A (Chief Medical Officer) has filed a Form 4 on Dermira, Inc.
Txns:
| Sold 2,500 shares
@ $25, valued at
$62.5k
Exercised 2,500 options to buy
@ $1.218, valued at
$3k
|
|
03/02/2018 |
4
| BAUER EUGENE A (Chief Medical Officer) has filed a Form 4 on Dermira, Inc.
Txns:
| Sold 500 shares
@ $25.316, valued at
$12.7k
Exercised 500 options to buy
@ $1.218, valued at
$609 |
|
02/16/2018 |
4
| BAUER EUGENE A (Chief Medical Officer) has filed a Form 4 on Dermira, Inc.
Txns:
| Granted 57,000 options to buy
@ $28.25, valued at
$1.6M
Granted 9,500 restricted stock units
@ $0 |
|
02/02/2018 |
4
| BAUER EUGENE A (Chief Medical Officer) has filed a Form 4 on Dermira, Inc.
Txns:
| Sold 3,000 shares
@ $28.5473, valued at
$85.6k
Exercised 3,000 options to buy
@ $1.218, valued at
$3.7k
|
|
01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/20/2017 |
4
| BAUER EUGENE A (Chief Medical Officer) has filed a Form 4 on Dermira, Inc.
Txns:
| Sold 3,000 shares
@ $27.3369, valued at
$82k
|
|
10/18/2017 |
4
| BAUER EUGENE A (Director) has filed a Form 4 on Aevi Genomic Medicine, Inc. |
10/13/2017 |
4
| BAUER EUGENE A (Chief Medical Officer) has filed a Form 4 on Dermira, Inc.
Txns:
| Sold 7,500 shares
@ $30.04, valued at
$225.3k
|
|
10/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/17/2017 |
4
| BAUER EUGENE A (Chief Medical Officer) has filed a Form 4 on Dermira, Inc.
Txns:
| Paid exercise price by delivering 987 shares
@ $23.58, valued at
$23.3k
Paid exercise price by delivering 306 shares
@ $23.58, valued at
$7.2k
Exercised 2,625 restricted stock units
@ $0 Exercised 813 restricted stock units
@ $0 |
|
08/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/31/2017 |
4
| BAUER EUGENE A (Director) has filed a Form 4 on Cerecor Inc.
Txns:
| Granted 8,357 options to buy
@ $0.57, valued at
$4.8k
|
|
07/06/2017 |
4
| BAUER EUGENE A (Chief Medical Officer) has filed a Form 4 on Dermira, Inc.
Txns:
| Sold 2,500 shares
@ $30.003, valued at
$75k
|
|
07/05/2017 |
4
| BAUER EUGENE A (Director) has filed a Form 4 on Cerecor Inc.
Txns:
| Granted 13,690 options to buy
@ $0.57, valued at
$7.8k
|
|
06/21/2017 |
4
| BAUER EUGENE A (Chief Medical Officer) has filed a Form 4 on Dermira, Inc.
Txns:
| Sold 2,500 shares
@ $30.0128, valued at
$75k
|
|
05/03/2017 |
4
| BAUER EUGENE A (Chief Medical Officer) has filed a Form 4 on Dermira, Inc. |
04/04/2017 |
4
| BAUER EUGENE A (Chief Medical Officer) has filed a Form 4 on Dermira, Inc. |
04/04/2017 |
4
| BAUER EUGENE A (Director) has filed a Form 4 on Cerecor Inc.
Txns:
| Granted 9,751 options to buy
@ $0.68, valued at
$6.6k
|
|
03/02/2017 |
4
| BAUER EUGENE A (Chief Medical Officer) has filed a Form 4 on Dermira, Inc. |
02/22/2017 |
4
| BAUER EUGENE A (Chief Medical Officer) has filed a Form 4 on Dermira, Inc. |
02/15/2017 |
4
| BAUER EUGENE A (Chief Medical Officer) has filed a Form 4 on Dermira, Inc. |
|